You can find the annual or quarterly income statement of FibroGen Ord Shs here for insights into the performance and operational efficiency of FibroGen Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total revenue

--1.08M

Revenue

--1.08M

Cost of revenue

---58.00K

Operating expenses

--6.45M

R&D expenses

--1.21M

Depreciation, depletion, and amortization

--192.00K

Operating profit

---5.37M

Net non-operating interest income (expenses)

Non-operating interest income

--931.00K

Non-operating interest expense

--2.08M

Special income (expenses)

---6.62M

Income before tax

---13.15M

Income tax

--0.00

Income after tax

---13.15M

Net income from continuous operations

---13.15M

Net income from discontinued operations

--213.78M

Net income attributable to controlling interests

--200.64M

Net income attributable to common shareholders

--200.64M

Basic earnings per share

--49.61

Diluted earnings per share

--49.61

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

